| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.47 | 0.005 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.49 | 0.005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |